Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Belatacept During Post Depletional Repopulation to Facilitate Tolerance in Renal Allograft Recipients

NCT00565773 is registered in ClinicalTrials.gov with Allan D Kirk, MD, PhD as lead sponsor.

NCT NCT00565773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00565773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Belatacept During Post Depletional Repopulation to Facilitate Tolerance in Renal Allograft Recipients
Lead sponsor
Allan D Kirk, MD, PhD
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
July 1, 2017
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

organ transplantation